Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis

Carcinogenesis

Volumn 21, Issue 8, 2000, Pages 1567-1572

  Papanikolaou, Alexandros ^a,b   Wang, Qian Shu ^a   Papanikolaou, Demetrios ^a   Whiteley, Herbert E ^a   Rosenberg, Daniel W ^a,b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; METHYLENE BLUE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; COLON BIOPSY; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DESCENDING COLON; DYSPLASIA; HISTOPATHOLOGY; INTESTINE CRYPT; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STAINING; STRAIN DIFFERENCE;

EID: 0033865758     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.5.567     Document Type: Article

References (34)

1. Azoxymethane-induced tumors and aberrant crypt foci in mice of different tumor susceptibility
2. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: Preliminary findings
3. Aberrant crypts: Potential preneoplastic lesions in the murine colon
4. Specificity study to evaluate induction of aberrant crypts in murine colons
5. Aberrant crypt foci in the colonic mucosa of rats treated with a genotoxic and nongenotoxic colon carcinogen
6. Aberrant crypts in human colonic mucosa: Putative preneoplastic lesions
7. Identification and quantification of aberrant crypt foci and microadenomas in the human colon
8. Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity
9. Carcinoembryonic antigen in human colonic aberrant crypt foci
10. Identification of dysplasia in human colonic aberrant crypt foci
11. Somatic APC and K-ras codon 12 mutations in aberrant crypt foci from human colons
12. Azoxymethane induces K-ras activation in the tumor resistant AKR/J mouse colon Mol
13. Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa
14. Molecular determinants of dysplasia in colorectal lesions
15. Histomorphological and immunohistochemical characterization of colonic aberrant crypt foci in rats: Relationship to growth factor expression
16. Aberrant crypt foci in human colons: Distribution and histomorphologic characteristics
17. Proliferative lesions of the intestine salivary glands oral cavity and esophagus in rats
18. Genetic differences in the induction of colorectal tumors by 1,2-dimethylhydrazine in inbred mice
19. Sequential analyses of the growth and morphological characteristics of aberrant crypt foci: Putative preneoplastic lesions
20. Comparative study of the morphologic, histochemical and proliferative changes induced in the large intestine of ICR/Ha and C57BL/Ha mice
21. Susceptibility to 1,2-dimethylhydrazine-induced colonic tumors and epithelial cell proliferation characteristics of F1, F2 and reciprocal backcrosses derived from SWR/J and AKR/J parental mouse strains
22. Quantitative assessment of azoxymethane-induced aberrant crypt foci in inbred mice
23. The secretory phospholipase A2 gene ix a candidate for the Moral locus a major modifier of ApcMin-induced intestinal neoplasia
24. A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in Apc(Min)/+ mice
25. Genetic identification of Mom-1 a major modifier locus affecting Min-induced intestinal multiple neoplasia in the mouse
26. Expression analysis of the group IIA secretory phospholipase A2 in mice with differential susceptibility to azoxymethane-induced colon tumorigenesis
27. Different genetic susceptibility to aberrant crypts and colon adenomas in mice
28. The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology
29. Natural history of aberrant crypt foci. A surgical approach
30. Aberrant crypt foci in patients with neoplastic and nonneoplastic colonic desease
31. Aberrant crypt foci of the colon as precursors of adenoma and cancer
32. Dietary factors in human colorectal cancer